logo

For the Inventor, By the Inventor

Bothell, WA, United States of America

Mediquest Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 17

% Expired Patents = 41.2



Forward Citations = 182

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Mark R Burns (12 out of 16 patents)

silverMedal Gerard F Graminski (4 out of 5 patents)

bronzeMedal Christine L O'Day (3 out of 6 patents)

4.  Donald E Bergstrom (2 out of 16 patents)

5.  Maralee McVean (2 out of 7 patents)

6.  Thomas P Dooley (2 out of 5 patents)

7.  Ernest V Curto (2 out of 3 patents)

8.  Frederick J Dechow (2 out of 2 patents)

9.  Kevin Kennedy (2 out of 2 patents)

10.  Arthur Yeung (2 out of 2 patents)

11.  Bruce H Devens (2 out of 2 patents)

12.  Nicolaas M J Vermeulin (2 out of 4 patents)

13.  Heather K Webb (2 out of 4 patents)

14.  Sunil Abraham David (2 out of 14 patents)

15.  Nicolaas M J Vermeulen (1 out of 26 patents)


17 patents:

1. 7858105 - Inhibitors of melanocyte tyrosinase as topical skin lighteners (2010-12-28),
2. 7776349 - Organo-gel formulations for therapeutic applications (2010-08-17),
3. 7740875 - Organo-gel formulations for therapeutic applications (2010-06-22),
4. 7718185 - Inhibitors of melanocyte tyrosinase as topical skin lighteners (2010-05-18),
5. 7432302 - Composition containing polyamine transport inhibitor and use thereof (2008-10-07),
6. 7411002 - Polycationic sulfonamides and use thereof (2008-08-12),
7. 7388112 - Immunomodulation with novel pharmaceutical compositions (2008-06-17),
8. 7232831 - Tetrahydro-β-carboline compounds and use thereof (2007-06-19),
9. 7208528 - Polyamine analogues as therapeutic and diagnostic agents (2007-04-24),
10. 7199267 - Recognition of oligiosaccaride molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases (2007-04-03),
11. 7160923 - Polyamine analogues as therapeutic and diagnostic agents (2007-01-09),
12. 7144920 - Polyamine analogs that activate antizyme frameshifting (2006-12-05),
13. 6963010 - Hydrophobic polyamine analogs and methods for their use (2005-11-08),
14. 6919483 - Immunomodulation with novel pharmaceutical compositions (2005-07-19),
15. 6914079 - Polyamine analogs that activate antizyme frameshifting (2005-07-05),
Company Overview
Mediquest Therapeutics, Inc. is a biotechnology company based in Bothell, Washington, specializing in the development of innovative therapies for autoimmune and inflammatory diseases. The organization focuses on leveraging advanced scientific research to create novel treatments that address unmet medical needs. Mediquest is dedicated to enhancing patient outcomes through its commitment to rigorous research and development in the biopharmaceutical sector, aiming to bring transformative solutions to the healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

17 Patents

#31 in Bothell, WA

#403 in Washington

#18,913 in US

#35,974 in the World

Bothell, WA (US)
Bothell, WA, United States of America

Mediquest Therapeutics, Inc.

Forward Citations = 182

19 inventors:

goldMedal Mark R Burns (12 out of 16 patents)

silverMedal Gerard F Graminski (4 out of 5 patents)

bronzeMedal Christine L O'Day (3 out of 6 patents)

4.  Donald E Bergstrom (2 out of 16 patents)

5.  Maralee McVean (2 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mediquest Therapeutics, Inc.. Retrieved from https://idiyas.com/company/mediquest-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…